Although the association between glutamate and glutamine in relation to cardiometabolic disorders has been evaluated, the role of these metabolites in the development of atrial fibrillation (AF) and heart failure (HF) remains unknown.
We examined associations of glutamate, glutamine, and the glutamine-to-glutamate ratio with AF and HF incidence in a Mediterranean population at high cardiovascular disease (CVD) risk.
The present study used 2 nested case-control studies within the PREDIMED (Prevención con Dieta Mediterránea) study. During ?10 y of follow-up, there were 509 AF incident cases matched to 618 controls and 326 HF incident cases matched to 426 controls. Plasma concentrations of glutamate and glutamine were semiquantitatively profiled with LC-tandem MS. ORs were estimated with multivariable conditional logistic regression models.
In fully adjusted models, per 1-SD increment, glutamate was associated with a 29% (95% CI 1.08, 1.54) increased risk of HF and glutamine-to-glutamate ratio with a 20%CTN35739639.Previous studies demonstrated that Transforming Growth Factor β1 (TGF-β1) plays an immunosuppressive role in clinical tuberculosis (TB). However, the contribution of TGF-β1 gene polymorphisms to human TB susceptibility remains undetermined. In this study, we showed that single nucleotide polymorphisms (SNPs) in TGF-β1 gene were associated with increased susceptibility to TB in the discovery cohort (1533 cases and 1445 controls) and the validation cohort (832 cases and 1084 controls), and two SNPs located in the promoter region (rs2317130 and rs4803457) are in strong linkage disequilibrium. The SNP rs2317130 was associated with the severity of TB. Further investigation demonstrated that rs2317130CC genotype is associated with higher TGF-β1 and IL-17A production. The mechanistic study showed rs2317130 C allele affected TGF-β1 promoter activity through regulating binding activity to nuclear extracts. These findings provide insights into the pathogenic role of TGF-β1 in human TB and reveal a function for the TGF-β1 promoter SNPs in regulating immune responses during Mycobacterium tuberculosis (Mtb) infection.Epidemiological studies suggest that higher fruits and vegetables (F&amp;V) consumption correlates with reduced risk of hepatic steatosis, yet evidence for causality and the underlying mechanisms is lacking.
We aimed to determine the causal relation between F&amp;V consumption and improved metabolic disorders in mice fed high-fat (HF) (Experiment-1) or normal-fat (Experiment-2) diets and its underlying mechanisms.
Six-week-old male C57BL/6J mice were randomly grouped and fed diets supplemented at 0%-15% (wtwt) with a freeze-dried powder composed of 24 commonly consumed F&amp;V (human equivalent of 0-9 servings/d) for 20 wk. In Experiment-1, mice were fed an HF (45%kcal fat) diet with 0% (HF0), 5%, 10%, or 15% (HF15) F&amp;V or a matched low-fat control diet (10%kcal fat). In Experiment-2, mice were fed an AIN-93 diet (basal) (B, 16%kcal fat) with 0% (B0), 5%, 10%, or 15% (B15) F&amp;V supplementation. Body weight and composition, food intake, hepatic steatosis, inflammation, ceramide levels, sphingomyell role of high F&amp;V intake in mitigating hepatic steatosis in mice. These beneficial effects may be mediated through changes in ceramide and/or gut microbiota, and suggest that higher than currently recommended servings of F&amp;V may be needed to achieve maximum health benefits.Choline plays an integral role in one-carbon metabolism in the body, but it is unclear whether genetic polymorphisms are associated with variations in plasma choline and its metabolites.
This study aimed to evaluate the association of genetic variants in choline and one-carbon metabolism with plasma choline and its metabolites.
We analyzed data from 1423 postmenopausal women in a case-control study nested within the Women's Health Initiative Observational Study. Plasma concentrations of choline, betaine, dimethylglycine (DMG), and trimethylamine N-oxide were determined in 12-h fasting blood samples collected at baseline (1993-1998). Candidate and tagging single-nucleotide polymorphisms (SNPs) were genotyped in betaine-homocysteine S-methyltransferase (BHMT), BHMT2, 5,10-methylenetetrahydrofolate reductase (MTHFR), methylenetetrahydrofolate dehydrogenase (NADP+ dependent 1) (MTHFD1), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and 5-methyltetrahydrofolate-homocysteine methyltransferasets metabolites. Our findings contribute to the knowledge on the variation in blood nutrient concentrations in postmenopausal women.
Genetic variations in metabolic enzymes were associated with plasma concentrations of choline and its metabolites. Our findings contribute to the knowledge on the variation in blood nutrient concentrations in postmenopausal women.Previous research suggested that there might be distinct patterns of functional decline in the last years of life depending on the condition leading to death, but the validity of these results and hence the explanatory value of the condition leading to death for late-life disability are uncertain.
A total of 636 decedents from a cohort of 754 community-living persons, 70+ years of age (Yale PEP Study) provided 33,700 monthly observations of self-/proxy-reported disability during the last 5 years of life. Non-linear trajectories and short-term fluctuations of late-life disability by condition leading to death (cancer, organ failure, frailty, severe dementia, sudden death, other) were estimated with flexible mixed spline regression models.
Disability trajectories at the end of life varied distinctively by the condition leading to death. Estimated disability trajectories among cancer deaths increased gradually up until about 6 months before death, after which a steep terminal decline set in. Among those with organ failure, frailty and dementia, in contrast, disability was higher, increased more gradually, and there was no clear-cut terminal phase. Adding the condition leading to death to other known risk factors increased the amount of explained between-person variation in late-life disability from R?=0.35 to 0.49. https://www.selleckchem.com/products/Y-27632.html Short-term fluctuations in disability were not specific for decedents with organ failure.
The condition leading to death is an important determinant of trajectories of late-life disability. These trajectories follow distinct patterns partially resembling a previously outlined theoretical typology.
The condition leading to death is an important determinant of trajectories of late-life disability. These trajectories follow distinct patterns partially resembling a previously outlined theoretical typology.